GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
20 hedge funds and large institutions have $11.3M invested in Grace Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$576K |
2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$496K |
3 |
Renaissance Technologies
New York
|
-$43.2K |
4 |
Citadel Advisors
Miami,
Florida
|
-$11.9K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.17K |